He was born in Valencia in 1963, and M.Sc. in Chemical Sciences (University of Valencia 1986). Doctor in Chemical Sciencies (University of Valencia 1990). Postdoctoral position in Cambridge (UK) in 1993-1994. Currently Full Professor in the Department of Chemistry at Universitat Politècnica de València. He is since 2015 Scientific Director of the Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) of Carlos III Health Institute (ISCIII). He is current Director of the Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), an inter-university research Institute between the Universitat Politècnica de València (UPV) and the Universitat de València. Additionally, he is Coordinator of the “Joint Research Unit in Nanomedicine and Sensors” with the Hospital La Fe in Valencia and the “Joint Research Unit in Disease Mechanisms and Nanomedicine” with the Centro de Investigación Príncipe Felipe.
Ramón Martínez Máñez has worked for more than twenty-five years in the design of molecular probes and chemosensors, which are entities in which changes in an easy-to-detect signal (usually colour or fluorescence) are observed upon recognition of target guests. He has developed work in this research field, specially designing chromo-fluorogenic probes for different chemicals of interest, including cations, anions, neutral molecules and biological species. He has also been working in the design of electrochemical sensors and electronic tongues for different applications. Another area in his research involves the design of functional hybrid materials for controlled delivery applications. He has designed smart on-command delivery systems, of drugs and other molecules, for different applications including nanomedicine.
He has published a total of 402 research articles in refereed journals. He has been cited more than 16,900 times (web of Science, 22,560 times in Google Scholar). He has an h-index of 60 (web of Science; h-index of 66 in Google Scholar) and has published 36 articles that have been cited more than 100 times. He is co-editor of a book, co-author of 17 book chapters and has supervised 37 PhD theses, 10 of which have obtained the UPV PhD Award. He holds 29 patents, 17 of them international. Four of these patents have been transferred to companies. He is co-founder of the spin-off Senolytic Therapeutics SL, created to transfer advances in drugs and nanodevices for targeting age-related diseases.
He has been named Co-Chairman of the journal ChemistryOpen and member of the International Advisory Board of the journals Chem.Asian J. and ChemPlusChem (all published by Wiley-VCH). He is coordinator of the Interuniversity PhD Program in Chemistry at the UPV, which obtained the prize of the Social Council of the UPV to the best doctoral program of the 2017/2018 academic year. In 2016 he was awarded with the Research Excellence Award by the Real Sociedad Española de Química (RSEQ). In 2018 he received the Rey Jaume I Award of New Technologies.